Analysis of factors influencing latent tuberculosis infection screening using QuantiFERON-TB Gold In-Tube in people living with HIV/AIDS

分析影响艾滋病毒/艾滋病感染者使用 QuantiFERON-TB Gold In-Tube 进行潜伏性结核感染筛查的因素

阅读:2

Abstract

OBJECTIVE: To investigate the influencing factors associated with the risk of latent tuberculosis infection (LTBI) among people living with HIV/AIDS (PLWHA). METHODS: A cross-sectional study was conducted from July 2023 to July 2024, recruiting PLWHA from Wuxi City and Yangzhou City, Jiangsu Province, China. Data were collected through on-site questionnaire surveys and review of patient disease management records. QuantiFERON-TB Gold In-Tube (QFT) was used to detect LTBI. Multivariate logistic regression analysis was performed to identify factors associated with LTBI among PLWHA. Restricted cubic splines (RCS) models were employed to analyze the dose-response relationships between CD4(+) cell count, CD8(+) cell count, and CD4/CD8 ratio with LTBI risk. RESULTS: A total of 1184 PLWHA were enrolled, with 8.4% having concomitant LTBI. Multivariate logistic regression revealed that age group 45-<60 years (OR = 2.158, 95% CI: 1.339-3.478, P = 0.002) and CD4/CD8 ratio ≥1 (OR = 3.562, 95% CI: 1.627-7.800, P = 0.001) were independent factors associated with LTBI. RCS model fitting results demonstrated a gradually increasing nonlinear dose-response relationship between continuous changes in CD4/CD8 ratio and LTBI. The dose-response relationship between CD4(+) cell count and LTBI risk exhibited an "initial increase followed by a decrease trend. The dose-response relationship between CD8(+) cell count and LTBI risk showed a gradual declining trend. CONCLUSION: This study identified that middle-aged PLWHA (45-<60 years) might represent a subgroup with relatively higher LTBI prevalence, indicating that screening in this age group may hold greater potential value. Additionally, the CD4/CD8 ratio, in conjunction with QFT findings, could serve as a supplementary reference for LTBI risk assessment. These observations support a more tailored approach to LTBI screening in PLWHA, though their implementation should be validated in prospective studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。